Discover 833 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 833
Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1
for
Traumatic Brain Injury
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 65
Code: NCT01239706
Phase2, Recruiting
Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT
for
Patent Ductus Arteriosus After Premature Birth
Location: Halifax, Quebec City, Oklahoma City OK, Edmonton,
Sponsor: IWK Health Centre
Sex: All
Age: 0
Code: NCT05011149
Phase3, Recruiting
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
for
Juvenile Idiopathic Arthritis
Location: St John's, Halifax, Montreal, Ottawa, Toronto, Hamilton,
Sponsor: The Hospital for Sick Children
Sex: All
Age: 0 - 18
Code: NCT06560606
Recruiting
Immune-Mediated Pathophysiology And Clinical Triage Program
for
Arthritis, Arthralgia
Location: Edmonton
Sponsor: AHS Cancer Control Alberta
Sex: All
Age: 18+
Code: NCT04354649
Phase2, Recruiting
Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft
for
Ankle and Hindfoot Arthrodesis
Location: Halifax, Hartford CT, Newark NJ, Philadelphia PA,
Sponsor: BioMimetic Therapeutics
Sex: All
Age: 18+
Code: NCT02879149
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
SMOFlipid and Incidence of BPD in Preterm Infants
for
Very Low Birth Weight Infant, Bronchopulmonary Dysplasia
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 0
Code: NCT04078906
Recruiting
Cannabidiol Medication Intervention Trial
for
Alzheimer Disease
Location: Whitby, Toronto, London, Calgary
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 55+
Code: NCT06014424
Phase2, Recruiting
Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada
for
Invasive Meningococcal Disease
Location: Saint John's, Halifax, Quebec, Montreal, Ottawa,
A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies
for
Cancer
Location: Saint John, Montreal, Ottawa, Toronto, Hamilton,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03847649
Phase2, Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
for
Moderately to Severely Active Crohn's Disease, Crohn Disease,